SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000921895-09-002883
Filing Date
2009-12-15
Accepted
2009-12-15 16:29:11
Documents
2

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO THE SCHEDULE 13D sc13da107422008_12152009.htm SC 13D/A 197940
2 STOCKHOLDERS AGREEMENT ex991to13da107422008_121509.htm EX-99.1 113166
  Complete submission text file 0000921895-09-002883.txt   313137
Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 6282 Investment Advice

Mailing Address 1500 SEAPORT BLVD. REDWOOD CITY CA 94063
Business Address 1500 SEAPORT BLVD. REDWOOD CITY CA 94063 650-454-1000
FACET BIOTECH CORP (Subject) CIK: 0001441848 (see all company filings)

IRS No.: 263070657 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-84407 | Film No.: 091242025
SIC: 2834 Pharmaceutical Preparations